Ligand Pharmaceuticals
LGND
#3614
Rank
NZ$6.28 B
Marketcap
NZ$319.08
Share price
-1.57%
Change (1 day)
54.86%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): NZ$0.11 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.25 Billion. In 2024 the company made an earning of NZ$9.22 Million a decrease over its 2023 earnings that were of NZ$0.10 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.11 B1098.31%
2024 NZ$9.22 M-91.37%
2023 NZ$0.10 B-7.59%
2022 NZ$0.11 B4%
2021 NZ$0.11 B296.42%
2020 NZ$28.04 M-97.97%
2019 NZ$1.38 B275.62%
2018 NZ$0.36 B237.48%
2017 NZ$0.10 B49.05%
2016 NZ$73.17 M55.41%
2015 NZ$47.08 M36.87%
2014 NZ$34.4 M29.59%
2013 NZ$26.54 M1309.35%
2012 NZ$1.88 M-43.97%
2011 NZ$3.36 M-113.19%
2010 -NZ$25.49 Million59.86%
2009 -NZ$15.95 Million-61.33%
2008 -NZ$41.24 Million-58.75%
2007 -NZ$99.96 Million20.52%
2006 -NZ$82.94 Million81.27%
2005 -NZ$45.76 Million
2003 -NZ$31.86 Million-20.6%
2002 -NZ$40.12 Million4.38%
2001 -NZ$38.44 Million-48.83%
2000 -NZ$75.11 Million-19.74%
1999 -NZ$93.58 Million-19.06%
1998 -NZ$0.12 Billion126.71%
1997 -NZ$51 Million-5.83%
1996 -NZ$54.15 Million136.23%
1995 -NZ$22.93 Million-33.97%
1994 -NZ$34.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$53.80 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$19.68 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$37.37 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$13.69 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-NZ$0.45 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.35 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.34 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$15.48 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA